Cite

MLA Citation

    Sergey Shcherbinin et al.. “TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment.” Alzheimer's & dementia, vol. 17, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100148202924.0x00002f
  
Back to record